Skip to content

AI-based Upper Limb Rehabilitation Therapy With MOTORE

Intelligent Robot-mediated Therapy With the MOTORE Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05238389
Acronym
iMotore
Enrollment
44
Registered
2022-02-14
Start date
2022-06-01
Completion date
2023-03-30
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Stroke is a common disease with a high disabling impact; it is the world's second leading cause of death and the third leading cause of disability. Robotic therapy has been proposed as a viable approach for the rehabilitation of the upper limb, as a way to increase the amount and the intensity of the therapy, and to standardize the treatment. However, robotic technologies have not yet been used to their full potential in terms of tailoring rehabilitation paths and monitoring the response to treatments. The main goal of the study is to use AI algorithms to (a) predict the recovery of the patients and (b) suggest exercises and parameters to improve the outcomes of the treatment.

Interventions

DEVICEAI-based upper limb robotic therapy

Patients will be treated using MOTORE, a robotic device that allows passive, active, and active-assistive planar movements of the shoulder and elbow joints. The intervention will consist of 30 sessions, 1 per day and 5 per week. Therefore, each patient will be treated for 6 weeks The parameters of the serious games will be proposed by a Decision Support System (DSS), based on an AI-based algorithm trained using data collected during a previous Randomized Controlled Trial. The DSS will be fed, at the enrollment, with patient's demographics, clinical characteristics, clinical scales and kinematic/kinetic data measured by the robot during an evaluation session (unassisted reaching movements) and updated every 2 sessions with kinematic/kinetic data only, to tailor the treatment to the patient's current abilities. The therapists will be free to use or not the suggested parameters, on the basis of their previous experience with the robot (over 3 years).

Sponsors

Fondazione Don Carlo Gnocchi Onlus
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* first ischemic or hemorrhagic stroke (verified by MRI or CT); * time since stroke onset between 1 and 6 months (subacute phase) * cognitive abilities adequate to understand the experiments and the follow instructions * upper limb impairment (Fugl-Meyer Assessment - Upper Extremity score ≤58);

Exclusion criteria

* fixed contractions in the affected limb (ankylosis, Modified Ashworth Scale equal to 4); * inability to understand the instructions required for the study; * behavioral disorders that may influence therapeutic activity; * other orthopedic or neurological diseases * inability or unwillingness to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Agreement between the physiotherapists and the decision support systemThrough the study, an average of 10 monthsThe number of times a physiotherapist refuses to accept the parameters proposed
System Usability ScaleAfter a 6-week robotic rehabilitation interventionIt is a self-administered questionnaire to evaluate usability. It ranges from 0 to 100. Higher scores mean better usability.
Technology Acceptance Model (TAM)After a 6-week robotic rehabilitation interventionIt is a self-administered questionnaire to evaluate the acceptance of the provided. It comprises several questions rated on a 7-point likert scale.
Likert for SatisfactionAfter a 6-week robotic rehabilitation interventionSatisfaction will be assessed using a 11-point likert scale. It ranges from 0 to 10. Higher scores mean higher satisfaction.

Secondary

MeasureTime frameDescription
Change in Frenchay Arm TestBefore the intervention, after a 3-week robotic rehabilitation interventionThe Frenchay Arm Test (FAT) is a measure of upper extremity proximal motor control and dexterity during activities of daily living in patients with upper limb impairments. The total scores range from 0 to 5 (normal performance).
Change in Modified Ashworth ScaleBefore the intervention, after a 3-week robotic rehabilitation interventionIt is a validated measure of spasticity. It ranges from 0 (normal) to 4 (rigid limb).
Changes in Motricity Index for upper extremityBefore the intervention, after a 3-week robotic rehabilitation interventionIt is a validated measure of upper limb strength. It ranges from 0 (worse) to 100 (normal strength).
Changes in Numeric Rating Scale for painBefore the intervention, after a 3-week robotic rehabilitation interventionThe Numerical Pain Rating Scale (NPRS) is a subjective measure in which individuals rate their pain on an eleven-point numerical scale, from 0 (no pain) to 10 (worst pain imaginable).
Changes in Neuropathic Pain 4 Questions (DN4)Before the intervention, after a 3-week robotic rehabilitation interventionIt is a validated clinician-administered screening tool for neuropathic pain. It ranges from 0 to 10; higher values means higher neuropathic pain probability.
Changes in Modified Barthel IndexBefore the intervention, after a 3-week robotic rehabilitation interventionThe modified is an ordinal scale used to measure performance in activities of daily living. It ranges from 0 to 100, with lower scores indicating increased disability.
Changes in Fugl-meyer Assessment Upper Extremity motor functioningBefore the intervention, after a 3-week robotic rehabilitation interventionIt is a stroke-specific, performance-based impairment index. It ranges from 0 (hemiplegia) to 66 points (normal).
Changes in the Duration Index.Before the intervention, after a 3-week robotic rehabilitation interventionThe kinematics of the end-effector of the robot will be acquired during reaching tasks performed by the patient without any assistance from the device. Specifically, Duration is the time required to complete the task. It is measured in seconds.
Changes in Velocity_mean Index.Before the intervention, after a 3-week robotic rehabilitation interventionThe kinematics of the end-effector of the robot will be acquired during reaching tasks performed by the patient without any assistance from the device. Specifically, Velocity\_mean is the average velocity of the device during the test. It is measured in m/s.
Changes in the Length_tot IndexBefore the intervention, after a 3-week robotic rehabilitation interventionThe kinematics of the end-effector of the robot will be acquired during reaching tasks performed by the patient without any assistance from the device. Specifically, Length\_tot is the global length of the path travelled by the subject during center-out movements. It is measured in meters and it ranges from 0 (no movement) to 2.808 m (patient can fully perform the entire task);
Changes in the Score Index.Before the intervention, after a 3-week robotic rehabilitation interventionThe kinematics of the end-effector of the robot will be acquired during reaching tasks performed by the patient without any assistance from the device. Specifically, Score is the mean of the ratios between the actual distance covered by the patients and the required distance to be travelled, computed for each required movement; it ranges from 0 (no movement) to 10 (the patient can fully perform the required task). It is a dimensionless index.
Changes in the Work_tan Index.Before the intervention, after a 3-week robotic rehabilitation interventionThe kinematics of the end-effector of the robot will be acquired during reaching tasks performed by the patient without any assistance from the device. Specifically, Work\_tan is the amount of total work directed towards the target. It is measured in Joules.
Changes in kinetic parameters: Force (N) towards 8 targetsBefore the intervention, after a 3-week robotic rehabilitation interventionThe kinetics of the end-effector of the robot will be measured by the robot during reaching tasks performed by the patient against the device. The outcome will be the maximum values towards 8 targets.
Changes in 36-Item Short Form Survey (SF-36)Before the intervention, after a 6-week robotic rehabilitation interventionThe 36-Item Short Form Survey (SF-36) is a self-reported measure of health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. The scores are: vitality; physical functioning; bodily pain; general health perceptions; physical role functioning; emotional role functioning; social role functioning; mental health. Moreover, two composite scores, i.e., the Physical Composite Score and the Mental Composite Score, both ranging from 0 to 100, will be considered.
Changes in Box and Block test (BBT)Before the intervention, after a 3-week robotic rehabilitation interventionThe BBT is a standard measure for evaluating manual dexterity. The participants grasp and transfer one-inch square blocks from one compartment to the other, transferring as many as possible. The number of blocks transferred from one side to the other within 1 min is recorded.
Changes in Action Research Arm Test (ARAT)Before the intervention, after a 3-week robotic rehabilitation interventionIt is a valid measure of upper-extremity functional limitation. The total score on the ARAT ranges from 0 to 57, with the lowest score indicating that no movements can be performed, and the upper score indicating normal performance.
Change in Medical Research Council (MRC)Before the intervention, after a 3-week robotic rehabilitation interventionIt is a validated measure of strength clinically measured. It ranges from 0, paralysis, to 5, normal strength.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026